These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1972964

  • 1. Design and synthesis of highly potent and selective cyclic dynorphin A analogues.
    Kawasaki AM, Knapp RJ, Kramer TH, Wire WS, Vasquez OS, Yamamura HI, Burks TF, Hruby VJ.
    J Med Chem; 1990 Jul; 33(7):1874-9. PubMed ID: 1972964
    [Abstract] [Full Text] [Related]

  • 2. Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs.
    Kawasaki AM, Knapp RJ, Kramer TH, Walton A, Wire WS, Hashimoto S, Yamamura HI, Porreca F, Burks TF, Hruby VJ.
    J Med Chem; 1993 Mar 19; 36(6):750-7. PubMed ID: 8096246
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11.
    Meyer JP, Collins N, Lung FD, Davis P, Zalewska T, Porreca F, Yamamura HI, Hruby VJ.
    J Med Chem; 1994 Nov 11; 37(23):3910-7. PubMed ID: 7966152
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD, Collins N, Stropova D, Davis P, Yamamura HI, Porreca F, Hruby VJ.
    J Med Chem; 1996 Mar 01; 39(5):1136-41. PubMed ID: 8676350
    [Abstract] [Full Text] [Related]

  • 6. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD, Meyer JP, Lou BS, Xiang L, Li G, Davis P, DeLeon IA, Yamamura HI, Porreca F, Hruby VJ.
    J Med Chem; 1996 Jun 21; 39(13):2456-60. PubMed ID: 8691442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.
    Lu Y, Nguyen TM, Weltrowska G, Berezowska I, Lemieux C, Chung NN, Schiller PW.
    J Med Chem; 2001 Sep 13; 44(19):3048-53. PubMed ID: 11543672
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence.
    Arttamangkul S, Murray TF, DeLander GE, Aldrich JV.
    J Med Chem; 1995 Jun 23; 38(13):2410-7. PubMed ID: 7608905
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis using a Fmoc-based strategy and biological activities of some reduced peptide bond pseudopeptide analogues of dynorphin A1.
    Meyer JP, Davis P, Lee KB, Porreca F, Yamamura HI, Hruby VJ.
    J Med Chem; 1995 Sep 01; 38(18):3462-8. PubMed ID: 7658433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors.
    Guerrini R, Capasso A, Marastoni M, Bryant SD, Cooper PS, Lazarus LH, Temussi PA, Salvadori S.
    Bioorg Med Chem; 1998 Jan 01; 6(1):57-62. PubMed ID: 9502105
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological activity of dynorphin-(1-13) and analogs substituted in positions 8 and 10.
    Lemaire S, Lafrance L, Dumont M.
    Int J Pept Protein Res; 1986 Mar 01; 27(3):300-5. PubMed ID: 2872177
    [Abstract] [Full Text] [Related]

  • 16. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS, Zheng MQ, Murray TF, Aldrich JV.
    J Med Chem; 2003 Sep 11; 46(19):4002-8. PubMed ID: 12954053
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological activity of analogs of dynorphin-A(1-13) substituted in positions 2 and 4: design of [Ala2,Trp4]-Dyn-A(1-13) as a putative selective opioid antagonist.
    Lemaire S, Turcotte A.
    Can J Physiol Pharmacol; 1986 Jun 11; 64(6):673-8. PubMed ID: 2875777
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues.
    Yoshino H, Nakazawa T, Arakawa Y, Kaneko T, Tsuchiya Y, Matsunaga M, Araki S, Ikeda M, Yamatsu K, Tachibana S.
    J Med Chem; 1990 Jan 11; 33(1):206-12. PubMed ID: 1967312
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues.
    Story SC, Murray TF, Delander GE, Aldrich JV.
    Int J Pept Protein Res; 1992 Aug 11; 40(2):89-96. PubMed ID: 1359999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.